Navigation Links
Danaher Reports Record Fourth Quarter 2012 Results
Date:1/29/2013

AAP measure should be considered in addition to, and not as a replacement for or superior to, GAAP operating cash flow, and may not be comparable to similarly titled measures used by other companies.

Danaher's management believes that this non-GAAP measure provides useful information to investors by reflecting an additional way of viewing aspects of Danaher's operations that, when  reconciled to GAAP operating cash flow, helps our investors to better understand the strength of Danaher's earnings as well as Danaher's ability to generate cash without external financings, strengthen its balance sheet, invest in the business and grow the business through acquisitions and other strategic opportunities.  A limitation of Danaher's free cash flow measure is that it does not take into account the Company's debt service requirements and other non-discretionary expenditures. 

 DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS (unaudited)
($ and shares in millions, except per share data)Three Months EndedYear EndedDecember 31,

2012December 31,

2011December 31,

2012December 31,

2011Sales

$

4,975.2$

4,716.6$

18,260.4$

16,090.5Cost of sales

(2,429.9)(2,389.5)(8,846.1)(7,913.9)Gross profit

2,545.32,327.19,414.38,176.6Operating costs and other:Selling, general and administrative expenses

(1,406.5)(1,287.7)(5,181.2)(4,607.7)Research and development expenses

(294.6)(282.1)(1,137.9)(1,018.5)Earnings from unconsolidated joint venture

18.921.969.966.8Operating profit

863.1779.23,165.12,617.2Non-operating income (expense):Loss on early extinguishment of debt

———(32.9)Interest expense

(40.8)(37.4)(157.5)(141.6)Interest income

1.00.33.25.1Earnings from continuing operations before income taxes

823.3742.13,010.82,447.8Income taxes

(192.9)(178.
'/>"/>

SOURCE Danaher Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
2. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
3. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
4. Cepheid Reports Fourth Quarter And Full Year 2012 Results
5. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
6. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
8. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
9. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
10. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
11. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 /PRNewswire/ ... VRX ) (TSX: VRX) ... directors nominated at its 2013 annual ... results of the vote for the ... below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo ...
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... , 21 de mayo de 2013 La ... compañías filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y ... para su junta. Guy Mayer, un ejecutivo ortopédico experimentado, ... David Johnson , un experto refutado ... Antes de unirse a OSI como presidente ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
... improvement solutions provider GP Strategies Corporation (NYSE: ... ended March 31, 2012. Overview of First Quarter ... quarter of 2012 compared to $64.3 million for first quarter of ... of 2012 compared to $4.3 million for first quarter of 2011 ...
... 2012 Valeant Pharmaceuticals International, Inc. (NYSE: ... that Valeant has agreed to acquire certain assets ... company focused on skincare products, for approximately $64 ... future revenue targets.  University Medical,s main brand is ...
Cached Medicine Technology:GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 2GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 3GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 4GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 5GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 6Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... MedMar Healing Center announces their participation in ... Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and clubs, ... goal is to raise food to help area kids who ... in recent years. , “We like being able to ... explains Douglas Chloupek of MedMar Healing Center. “Taking part in ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... 2013 The nation’s first trial involving ... nearing its conclusion in Washington state court, Bernstein Liebhard ... yesterday, an attorney for the Plaintiffs compared Intuitive Surgical ... tie sales and services for its customers. ... control of surgeons, to keep control of hospitals and ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
Breaking Medicine News(10 mins):Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2
... MONICA, Calif., Dec. 7 California,s,stem cell agency ... it was,rejecting 10 applications for research grants because ... billion stem cell program, the,Foundation for Taxpayer and ... consumer advocacy organization added that,to completely resolve the ...
... Dec. 7 Legendary blues artists Bobby,Rush and James ... the inaugural Mississippi Blues Marathon and Half-Marathon on Saturday,January ... & Mal,s, located at 200,South Commerce Street, in downtown ... scheduled to go on stage at 8:00 p.m., and ...
... for four blood proteins may provide a less-invasive follow-up for ... tomography (CT) scans, according to a new study led by ... a very high false positive rate when trying to discover ... Duke and lead investigator on the study. What that leads ...
... BioHorizons Implant Systems,Inc. relocated its global ... 44,000 square foot facility. The new facility, ... services, a newly,formed manufacturing facility and a ... surface treatment and packaging services., The ...
... 7 As of December 7,2007, Coshocton County Memorial ... nurses for a 3-year contract. As a result,bargaining unit ... strike,and maintain a picket line starting at 7:00 a.m. ... highly developed skills and extensive,education. Each and every day ...
... BAN(R)/Seventeen.com Stress Relief Survey are in, NEW YORK, Dec. ... and messy breakups anymore. The fast-paced world we live in ... people, especially young,women, face. This trend can be seen in ... what are some of the factors that contribute,to this new ...
Cached Medicine News:Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 2Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 3Health News:Study points to possibility of blood test to detect lung cancer 2Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 3Health News:What Stresses Teens Out 2Health News:What Stresses Teens Out 3
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... Liquichek Lipids Control is ... product that provides the ... analyte levels for lipids ... C-Reactive Protein in levels ...
... Control (Human) provides a comprehensive analyte ... and CO2. It requires no special ... major instruments and methodologies. Available in ... sizes (10 mL fill size available ...
Medicine Products: